TB-500 claims are even harder to evaluate TB-500 has a slightly different story
Oral semaglutide 2550 mg produces the largest average reduction, followed by orforglipron closely behind ( Nausea and vomiting increase with higher semaglutide exposure, with the 50 mg oral dose showing the greatest frequency, especially during dose escalation
H.TsaiW
The nasal spray supply format of TB-500 is of specific interest in systemic wound healing research models where repeated injectable use creates confounding tissue effects at injection sites
GHK-Cu Biocosmetic Cream (GHK-Cu 3% / Estriol 0.003%) $100/30gm Compounded 3% GHK-Cu with 0.003% topical estriol
With hundreds of published studies, it is one of the most researched peptides in regenerative biology demonstrating systemic activity across tendons, ligaments, muscle, bone, gut epithelium, and neural tissue through the nitric oxide system, growth hormone receptor signaling, and angiogenic pathways